The Mosquito Borne Disease Market is Anticipated to Witness High Growth Owing to Growing Prevalence of Mosquito Borne Diseases

The mosquito borne disease market involves products such as diagnostic equipment, therapeutic drugs, and preventive vaccines for mosquito borne diseases like malaria, dengue, chikungunya, Zika virus, yellow fever, and others. The increasing prevalence of mosquito borne diseases due to factors like changing climate conditions, urbanization, and international travel & trade has created a high demand for diagnostic tests, drugs, and vaccines to diagnose and treat these diseases. The growing awareness regarding mosquito borne disease diagnosis and management is also propelling the market growth. 

Key Takeaways

Key players operating in the Mosquito Borne Disease Market Size are Masimo, Medtronic Plc, Nihon-Kohden Corporation, GE Healthcare, Koninklijke Philips N.V., Hill-Rom Services, Inc.,Smiths Medical, Nonin, MICROTEK, OSI Systems, Inc. Honeywell International Inc., Promed Technology Co.Ltd., Beurer, Contec Medical Systems Co., Ltd., ChoiceMMed, CONMED Corporation, Stryker, Medline Industries, Inc., Curbell Medical Products, Inc., and Ecomed. The market players are focusing on new product launches, mergers, acquisitions, and global expansion to strengthen their market presence.

The rising global burden of mosquito borne diseases and growing demand for advanced diagnosis and treatment options provide numerous opportunities for market players to invest in R&D and launch innovative and low-cost products. Additionally, with increasing global healthcare expenditures, rising awareness in developing regions, and supportive government initiatives, the mosquito borne disease market is expected to witness robust growth in emerging markets of Asia Pacific, Latin America, Middle East, and Africa in the coming years.

Market Drivers and Restraints

The key drivers for the mosquito borne disease market include the growing prevalence of mosquito borne diseases globally, rising healthcare expenditure in developing nations, increasing focus on mosquito control and elimination programs, and technological advancements in diagnostic devices and testing kits. As per the WHO, there were about 228 million cases of malaria reported worldwide in 2018 alone. Additionally, diseases like dengue, zika and chikungunya are also on the rise across tropical and subtropical regions. This has boosted the demand for effective diagnostic testing and therapeutic drugs.

However, high costs associated with advanced disease diagnostic devices and lack of awareness regarding disease symptoms in remote areas hampers the market growth. Additionally, lack of healthcare infrastructure and shortage of skilled professionals in developing regions also poses challenges. Compliance issues with diagnostic procedures and ambiguity over disease symptoms also act as a restraint.

Segment Analysis
The mosquito borne disease market can be segmented based on diseases into Malaria, Dengue, Chikungunya, Zika virus, filariasis, Japanese encephalitis and others. Among these, the malaria segment accounts for the highest share of the market presently as malaria accounts for over 200 million cases annually across the world as per WHO report. It is considered as one of the most dominant and deadly mosquito borne disease which contributes significantly to global disease burden.

The market can also be segmented based on product type into diagnostic instruments, rapid diagnostic tests (RDTs), Drugs & Vaccines, repellents and others. Among these, the rapid diagnostic tests (RDTs) segment dominates the market currently due to the emergence of affordable and easy-to-use RDT kits for malaria, dengue and chikungunya. Early diagnosis of such diseases is crucial for efficient treatment and disease management.

Regional Analysis
The Asia Pacific region accounts for the largest share in the mosquito borne disease market due to high disease prevalence and developing nations like India and China facing challenges due to disease burden and lack of adequate diagnostic facilities. As per recent WHO report, around 88% of estimated global malaria cases occur in Africa region alone making it the dominating region. Latin American countries are also vulnerable to mosquito borne diseases like dengue, zika and chikungunya accounting for significant market share. Developed regions like North America and Europe also contribute to the market growth due to increasing global travel and international trade activities.

Get More Insights On This Topic: Mosquito Borne Disease Market